Experience

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of €2.25 billion aggregate principal amount of senior notes, consisting of €1.25 billion floating…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Taiwan of $185 million aggregate principal amount of floating-rate notes due 2021.  Banco…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Switzerland of CHF125 million aggregate principal amount of 0.350% fixed-rate notes due 2025.  …

Davis Polk advised the underwriter in connection with an SEC-registered Schedule B debt offering by KEXIM of $200 million aggregate principal amount of its floating-rate notes due 2018…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $2.85 billion aggregate principal amount of 2.350% notes due 2019, $2.85 billion…

Davis Polk advised the joint book-running managers in connection with an offering by Eastman Chemical Company of €200 million aggregate principal amount of its 1.50% notes due 2023 and €500…

Davis Polk advised the remarketing agents on the remarketing of $345 million aggregate principal amount of Stanley Black & Decker’s 1.622% subordinated notes due November 17, 2018,…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by AbbVie Inc. of €3.6 billion aggregate principal amount of senior notes in three…

Davis Polk advised the joint book-running managers in connection with an SEC-registered reopening of €200 million aggregate principal amount of 1.850% senior notes due 2023 by Bunge Finance…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3.25 billion aggregate principal amount of 2.625% fixed-rate senior notes due 2021. The lead…